lopinavir_ritonavir: profile and news
GlaxoSmithKline and Vertex Pharmaceuticals Announce Preliminary 48 ... 16 May 2006
Lexiva (Telzir; fosamprenavir calcium) 700 mg plus ritonavir 100 mg given twice daily was comparable (non-inferior) to Kaletra (lopinavir/ritonavir fixed-dose ... - PR Newswire (press release),
Abbott issued positive EU opinion for Kaletra tablets May 2, 2006
The European Commission decision regarding marketing authorization for Kaletra (lopinavir/ritonavir) is expected within 90 days. ... - Pharmaceutical Business Review
Bristol-Myers Squibb and Gilead Sciences Submit New Drug ... Apr 27, 2006
Drug interactions have been observed when didanosine, atazanavir, or lopinavir/ritonavir are co-administered with Viread, a component of Truvada, and dose ... - International News Service,
More Empty Promises: Abbott Fails to Supply Critical New AIDS Drug ... Apr 27, 2006
MSF urges the Chicago-based drug company to take immediate steps to make the heat-stable tablet version of lopinavir/ritonavir, marketed as Kaletra, available ... - Doctors Without Borders,
Fighting HIV — Lessons from Brazil May 10, 2006
Instead, the government reached an agreement last year with Abbott almost halving the price of the drug Kaletra (lopinavir–ritonavir), and it continues to ... - New England Journal of Medicine (subscription),
Starting treatment with Kaletra involves greater risk of increased ... Apr 24, 2006
Individuals taking an antiretroviral regimen containing the protease inhibitor Kaletra (lopinavir/ritonavir) appear to have the highest risk of developing high ... - Aidsmap,
US firm asked to cut price of drug regimen May 1, 2006
...response from the US manufacturer who said Abbot Laboratories would sell the new version of the second-line fixed dose combination lopinavir/ritonavir (LPV/r ... - Bangkok Post,
FDA: Adult HIV Treatment Guidelines Updated May 4, 2006
Tables have been revised to include up-to-date information about drug interactions and about the lopinavir/ritonavir 200/50 mg tablet formulation. ... - PharmaLive.com (press release),
(PRN) - UN Foundation Malaria Prevention Program Featured in ... Apr 28, 2006
...[+]. (PRN) - Abbott's New Tablet Formulation of Kaletra(R) (Lopinavir/Ritonavir) Receives Positive Opinion From the European Medicines Agency ... [+. ... - Bolsamania.com,
Tablet version of Kaletra receives European green light; MSF calls ... Apr 28, 2006
Abbott’s new tablet formulation of Kaletra (lopinavir/ritonavir) has received a positive opinion from the scientific committee of the European Medicines ... - Aidsmap,
